Proteon Pharmaceuticals

Proteon Pharmaceuticals is a pioneer in bacteriophage technology for sustainable animal protein production. The company develops targeted phage cocktails as feed additives for poultry, aquaculture, and dairy, addressing critical challenges like gut dysbiosis, bacterial infections, and foodborne pathogens. Its mission is to provide farmers with effective tools to reduce antibiotic dependence, improve animal health and productivity, and advance environmental sustainability. With over 15 years of dedicated research, Proteon positions itself at the intersection of animal health, food safety, and the global fight against AMR.

Patented bacteriophage platform utilizing precision biology and full genome sequencing to design and produce targeted phage cocktails for modulating microbiomes and combating bacterial pathogens in animals.

Proteon competes in the animal health feed additives market against established antibiotic producers, other alternative products (probiotics, prebiotics, organic acids), and a growing cohort of biotechnology startups developing phage-based solutions. Its differentiation lies in its long-standing phage expertise and focus on precision microbiome modulation.